IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

NOBILE ORAZIO, EDUARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 29.367
NA - Nord America 19.686
AS - Asia 13.956
SA - Sud America 2.403
OC - Oceania 386
AF - Africa 295
Continente sconosciuto - Info sul continente non disponibili 10
Totale 66.103
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.331
GB - Regno Unito 10.661
IT - Italia 5.233
CN - Cina 4.286
SG - Singapore 2.431
DE - Germania 2.362
SE - Svezia 2.102
RU - Federazione Russa 1.721
JP - Giappone 1.644
TR - Turchia 1.460
IN - India 1.256
BR - Brasile 1.255
FR - Francia 1.185
KR - Corea 1.082
IE - Irlanda 922
CA - Canada 821
NL - Olanda 801
ES - Italia 797
FI - Finlandia 643
UA - Ucraina 627
PL - Polonia 488
VN - Vietnam 469
MX - Messico 405
EU - Europa 391
AR - Argentina 366
CO - Colombia 348
AU - Australia 347
CH - Svizzera 277
ID - Indonesia 272
DK - Danimarca 265
BE - Belgio 234
TW - Taiwan 223
GR - Grecia 211
CL - Cile 185
AT - Austria 158
PT - Portogallo 130
TH - Thailandia 130
PE - Perù 125
RO - Romania 119
HK - Hong Kong 104
IL - Israele 73
SA - Arabia Saudita 65
HU - Ungheria 62
PK - Pakistan 61
IR - Iran 59
EG - Egitto 56
MA - Marocco 55
PH - Filippine 54
EC - Ecuador 52
BD - Bangladesh 49
ZA - Sudafrica 49
CZ - Repubblica Ceca 45
RS - Serbia 45
TN - Tunisia 44
MY - Malesia 43
NO - Norvegia 42
SI - Slovenia 38
NZ - Nuova Zelanda 37
HR - Croazia 35
UY - Uruguay 29
SK - Slovacchia (Repubblica Slovacca) 25
LT - Lituania 24
KW - Kuwait 22
BO - Bolivia 21
AE - Emirati Arabi Uniti 20
GT - Guatemala 20
KZ - Kazakistan 19
NP - Nepal 19
BG - Bulgaria 18
KE - Kenya 18
DZ - Algeria 16
EE - Estonia 16
IQ - Iraq 16
LU - Lussemburgo 16
PR - Porto Rico 16
JO - Giordania 15
BY - Bielorussia 14
ET - Etiopia 14
HN - Honduras 14
LV - Lettonia 14
CY - Cipro 13
MQ - Martinica 13
CR - Costa Rica 12
CU - Cuba 12
LB - Libano 12
SV - El Salvador 11
VE - Venezuela 11
UZ - Uzbekistan 10
PA - Panama 9
PY - Paraguay 9
BA - Bosnia-Erzegovina 8
OM - Oman 8
AZ - Azerbaigian 7
LY - Libia 7
MK - Macedonia 7
PS - Palestinian Territory 7
SN - Senegal 7
AL - Albania 6
IS - Islanda 6
KG - Kirghizistan 6
Totale 66.398
Salva come PNG Salva come JPEG
Città #
Southend 9.397
Seattle 1.735
Chandler 1.600
Singapore 1.441
Milan 1.307
Princeton 1.190
Wilmington 959
Dublin 916
Beijing 775
Redwood City 653
Council Bluffs 628
Redmond 571
Ashburn 570
Nanjing 458
Fairfield 453
Mountain View 443
Toronto 432
Ann Arbor 418
Des Moines 413
Tokyo 393
Bengaluru 391
Frankfurt am Main 391
Sakarya 381
Houston 337
Santa Clara 336
Rome 330
Boardman 322
Woodbridge 321
Dearborn 313
New York 299
Warsaw 292
Shanghai 253
Jacksonville 248
São Paulo 194
Jinan 193
Shenyang 192
Buenos Aires 176
Paris 175
Berlin 168
London 162
Cambridge 158
Hebei 157
Bogotá 150
Eitensheim 147
Guangzhou 139
Athens 138
Chicago 135
Madrid 134
Nanchang 127
Dong Ket 125
Istanbul 124
Phoenix 124
Santiago 115
Changsha 114
Barcelona 112
Bitonto 110
Taipei 110
Brussels 108
Andover 106
Duncan 105
San Diego 101
Tianjin 99
Los Angeles 97
Jakarta 96
Turin 94
Prato 92
Serra 92
Somerville 92
Mumbai 87
Nuremberg 87
Lima 86
Zhengzhou 83
Helsinki 82
Rotterdam 81
Vienna 79
Boston 78
Jiaxing 78
Florence 77
Ankara 76
Sunnyvale 73
Amsterdam 72
Sydney 70
Hanover 68
Moscow 67
Bangkok 66
Verona 66
Fuzhou 62
Hangzhou 62
Padova 62
Zurich 60
Chengdu 59
Wuhan 59
Medellín 58
Naples 58
Ottawa 57
Philadelphia 54
Montreal 51
Porto Alegre 49
Grafing 47
Rio de Janeiro 47
Totale 35.688
Salva come PNG Salva come JPEG
Nome #
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision 3.478
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 3.399
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision 3.278
Regional variation of Guillain-Barré syndrome 2.812
Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial) : a double-blind, multicentre, randomised controlled trial 1.086
Management of chronic inflammatory demyelinating polyradiculopathy 785
Comparing treatment options for chronic inflammatory neuropathies and choosing the right treatment plan 782
Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature 532
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 498
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 492
Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database 457
The complement story in Guillain-Barré syndrome : from pathogenesis to therapy 448
Impact of environmental factors and physical activity on disability and quality of life in CIDP 440
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies 429
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy 396
Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies 393
Validation of the Italian version of the Neuropathic Pain Symptom Inventory (NPSI) in peripheral nervous system diseases 353
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy 344
Anti-ganglioside antibodies : experience from the Italian Association of Neuroimmunology external quality assessment scheme 340
Treatment for IgG and IgA paraproteinaemic neuropathy 339
Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database 320
Rilevanza diagnostica degli anticorpi antinervo nelle neuropatie disimmuni 304
Compliance with international guidelines for chronic inflammatory neuropathies 301
231st ENMC International Workshop:. International Standard for CIDP Registry and Biobank, Naarden, The Netherlands, 12-14 May 2017 266
Clinical, electrophysiological and VEGF 2-year response after lenalidomide or stem cell transplantation in patients with POEMS syndrome 261
Response to: SARS-CoV-2 associated Guillain-Barré syndrome in 62 patients 246
Juvenile Chronic Inflammatory Demyelinating Polyneuropathy Epidemiology in Sardinia, Insular Italy 243
Home monitoring of maintenance intravenous immunoglobulin therapy in patients with chronic inflammatory neuropathy 234
Functioning and quality of life in patients with neuropathy associated with anti-MAG antibodies 211
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: Data from the Italian CIDP database 187
Cerebrospinal fluid total protein determination in acute and chronic inflammatory demyelinating polyneuropathies : A critical reappraisal 186
Pathophysiological heterogeneity of conduction blocks in multifocal motor neuropathy 184
What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection 182
Modifying the Medical Research Council grading system through Rasch analyses 182
Corticosteroids in chronic inflammatory demyelinating polyneuropathy : a retrospective, multicentre study, comparing efficacy and safety of daily prednisolone, pulsed dexamethasone, and pulsed intravenous methylprednisolone 179
Clinical Reasoning: A case of COVID-19 associated pharyngeal-cervical-brachial variant of Guillain-Barré syndrome 176
A novel MAPT mutation associated to late-onset spinal muscular atrophy without dementia in a large Italian family 175
Immunofissazione: principi generali e applicazione alla elettroforesi del liquido cerebrospinale 172
Low levels of LTB4 in cerebrospinal fluid of AIDS patients with cryptococcal meningitis 171
Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block 164
Aumento della concentrazione liquorale di leucotriene B4 in pazienti con AIDS 161
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 160
Rasch-built overall disability scale for multifocal motor neuropathy (RODs-MMN) 157
Polymorphisms of the TNF-alphagene in italian GBS patients 155
Survival motor neuron (SMN1 and SMN2) genes copy number in multifocal motor neuropathy 154
Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy 151
Guillain-Barré syndrome after combined CHOP and rituximab therapy in non-hodgkin lymphoma 148
A novel MAPT mutation associated to late-onset spinal muscular atrophy without dementia in a large Italian family 147
Unraveling gene expression profiles in peripheral motor nerve from Amyotrophic Lateral Sclerosis patients : insights into pathogenesis 147
Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies 145
IVIg in idiopathic autoimmune neuropathies: analysis in the light of the latest results 141
Changes in neuroimmunological pattern in IVIg treated-MMN patients : a long term follow up 141
Role of TNF-alpha in modulating GBS phenotype in Italian patients 140
IqYmune® is an effective maintenance treatment for multifocal motor neuropathy: A randomised, double-blind, multi-center cross-over non-inferiority study vs Kiovig®—The LIME Study 139
A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy 138
Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues 137
How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? 137
Pathophysiology of conduction block in multifocal motor neuropathy 136
Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis 135
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP : Clinical relevance of IgG isotype 134
Venous thromboembolism in acute stroke. Prognostic importance of hypercoagulability 133
Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenetic studies 132
A sporadic, atypical case of desminopathy: morphological and immunological characterization 132
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 132
Severe chronic sensory-motor polyneuropathy: coexistence of 3 unrelated etiologies in a type 1 diabetic patient. A case report and review of the literature 131
Long term efficacy of Rituximab in anti-MAG polyneuropathy 130
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society : first revision 130
Anti-MAG and anti-SGPG antibodies in neuropathy 130
Treatment for IgG and IgA paraproteinemic neuropathy 129
Guillain-Barré syndrome after combined chemoteharpy and Rituximab in non-Hodgkin’s lymphoma 128
A case-control study of anti-ganglioside and anti-Campylobacter Jejuni antibodies in Guillain-Barré syndrome in Western Lombardia 128
CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS 125
European Federation of Neurological Societies Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society 123
A 6-month randomized, controlled trial of intravenous immunoglobulins versus intravenous methylprednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (IMC Study) 123
A new antigen specificity of the M-protein in a patient with neuropathy and macroglobulinemia 123
Peripheral neuropathy and IgM paraproteins: an immunopathogenetic study 123
Sindrome di Guillain-Barré e altre neuropatie immunomediate 122
Abnormal expression of cyclin-dependent kinase in an atypical case of desminopathy 122
Neuropathy and monoclonal gammopathy 121
Multifocal motor neuropathy : Current concepts and controversies 120
Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins 120
Efficacy and tolerability of different brandof IVIg in the maintenance treatment of chronic immune mediated neuropathy 120
Anti-sulfatide IgM antibodies in peripheral neuropathy : to test or not to test? 120
IgM paraproteinaemic neuropathies 119
Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line 119
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 119
Vascular Endotelial growth factor serum concentration and diabethic neuropathy 119
How-long is IVIg effective in multifocal motor neuropathy? 117
Treatment of dysimmune neuropathies 117
Recurrent atrial fibrillation after subcutaneous apomorphine 117
Anti-GM1 IgM antibodies in motor neuron disease and neuropathy 117
Prognostic significance of hyperglycemia in acute stroke 117
Peripheral neuropathy in macroglobulinemia: incidence and antigen-specificity of M proteins 117
VEPs studies in patients with peripheral neuropaty and macroglobulinemia 116
Cost-Utility Analysis of Intravenous Immunoglobulin and Prednisolone for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 115
Cerebellar degeneration and hearing loss in a patient with idiopathic myenteric ganglionitis 114
Long term disability and social status change after Guillain-Barré syndrome 114
Autoimmunity in painful sensory neuropathy 114
Multifocal Motor Neuropathy 114
Oculopharyngeal myopathy with partial cytochrome c oxidase deficiency 114
Totale 33.204
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.939
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.541 0 0 0 0 0 0 0 0 759 1.135 364 283
2020/20217.571 257 424 601 264 708 510 448 427 797 457 1.872 806
2021/20226.528 564 326 297 365 658 567 370 348 731 616 563 1.123
2022/20237.784 933 578 646 811 843 1.460 289 474 820 236 377 317
2023/20249.755 331 669 614 818 1.437 665 742 901 475 883 1.120 1.100
2024/202510.342 912 1.275 883 1.391 1.593 777 804 1.627 1.080 0 0 0
Totale 70.266